Compounds > ly 274614
Page last updated: 2024-09-03

ly 274614 and levorphanol

ly 274614 has been researched along with levorphanol in 1 studies

Compound Research Comparison

Studies
(ly 274614)		Trials
(ly 274614)		Recent Studies (post-2010)
(ly 274614)		Studies
(levorphanol)		Trials
(levorphanol)		Recent Studies (post-2010) (levorphanol)
960156342618

Protein Interaction Comparison

ProteinTaxonomyly 274614 (IC50)levorphanol (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)8
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)2.6
Mu-type opioid receptorHomo sapiens (human)0.0001
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)4.45
Delta-type opioid receptorHomo sapiens (human)0.004
Kappa-type opioid receptorHomo sapiens (human)0.004
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0006
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)2.6
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)4.45
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)4.45

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, RM; Dykstra, LA; Granger, AL1

Other Studies

1 other study(ies) available for ly 274614 and levorphanol

ArticleYear
The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:2

    Topics: Animals; Drug Synergism; Isoquinolines; Levorphanol; Male; Morphine; Narcotics; Pain; Reaction Time; Receptors, Opioid, mu; Saimiri

2003